作者: Yingfang Tian , Michelle L. Apperson , Bradley P. Ander , Dazhi Liu , Boryana S. Stomova
DOI: 10.1016/J.JNEUROIM.2010.09.001
关键词:
摘要: Abstract Using whole genome exon microarrays 120 exons were differentially expressed between medication-free multiple sclerosis (MS) subjects in remission and healthy control (HS) (p |1.2|). These differentiated MS from HS using cluster analyses, principal components analyses (PCAs) cross-validation. In addition, 340 genes (transcripts) predicted to be alternatively spliced compared HS. findings may provide insight into the pathophysiology of potentially prognostic diagnostic biomarkers. However, given that comparisons performed on a very small sample, these preliminary require confirmation much larger independent cohort.